Telemedicine — Evaluation of an Online Telemedicine Course Through Facebook
Citation(s)
Celes RS, Rossi TRA, de Barros SG, Santos CML, Cardoso C [Telehealth as state response strategy: systematic reviewLa telesalud como estrategia de respuesta del Estado: revisión sistemática]. Rev Panam Salud Publica. 2018 Aug 10;42:e84. doi: 10.26633/RPSP.2018.84. eCollection 2018. Review. Portuguese.
dos Santos Ade F, Alves HJ, Nogueira JT, Torres RM, Melo Mdo C Telehealth distance education course in Latin America: analysis of an experience involving 15 countries. Telemed J E Health. 2014 Aug;20(8):736-41. doi: 10.1089/tmj.2013.0291. Epub 2014 Jun 5.
Edirippulige S, Armfield NR Education and training to support the use of clinical telehealth: A review of the literature. J Telemed Telecare. 2017 Feb;23(2):273-282. doi: 10.1177/1357633X16632968. Epub 2016 Jul 8. Review.
Ellaway R, Masters K AMEE Guide 32: e-Learning in medical education Part 1: Learning, teaching and assessment. Med Teach. 2008 Jun;30(5):455-73. doi: 10.1080/01421590802108331.
Ghanem O, Logghe HJ, Tran BV, Huynh D, Jacob B Closed Facebook™ groups and CME credit: a new format for continuing medical education. Surg Endosc. 2019 Feb;33(2):587-591. doi: 10.1007/s00464-018-6376-9. Epub 2018 Aug 13.
Masters K, Ellaway R e-Learning in medical education Guide 32 Part 2: Technology, management and design. Med Teach. 2008 Jun;30(5):474-89. doi: 10.1080/01421590802108349.
Pander T, Pinilla S, Dimitriadis K, Fischer MR The use of Facebook in medical education--a literature review. GMS Z Med Ausbild. 2014 Aug 15;31(3):Doc33. doi: 10.3205/zma000925. eCollection 2014. Review.
Pathipati AS, Azad TD, Jethwani K Telemedical Education: Training Digital Natives in Telemedicine. J Med Internet Res. 2016 Jul 12;18(7):e193. doi: 10.2196/jmir.5534.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
